New Mexico Cancer Care Alliance

Organization Overview

New Mexico Cancer Care Alliance is located in Albuquerque, NM. The organization was established in 2003. According to its NTEE Classification (H80) the organization is classified as: Specifically Named Diseases Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. New Mexico Cancer Care Alliance is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.

For the year ending 06/2023, New Mexico Cancer Care Alliance generated $1.4m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 8 years, the organization has seen revenues fall by an average of (6.2%) each year. All expenses for the organization totaled $1.6m during the year ending 06/2023. As we would expect to see with falling revenues, expenses have declined by (3.8%) per year over the past 8 years. You can explore the organizations financials more deeply in the financial statements section below.

Mission & Program ActivityExcerpts From the 990 Filing

TAX YEAR

2023

Describe the Organization's Mission:

Part 3 - Line 1

PROVIDE NM CANCER PATIENTS AND THEIR FAMILIES ACCESS TO THE LATEST RESEARCH, TECHNOLOGIES, AND CLINICAL SERVICES AND CONDUCT EDUCATIONAL PROGRAMS AND ALSO PROVIDE ONCOLOGY STUDIES THROUGHOUT NM.

Describe the Organization's Program Activity:

Part 3 - Line 4a

THE ORGANIZATION PROVIDES NEW MEXICO CANCER PATIENTS AND THEIR FAMILIES ACCESS TO THE LATEST RESEARCH, TECHNOLOGIES, AND CLINICAL SERVICES IN PREVENTION, SCREENING, DETECTION, DIAGNOSIS/STAGING, TREATMENT, SUPPORTIVE CARE, AND CONTINUED SURVEILLANCE THROUGH COLLABORATION AMONG PUBLIC AND PRIVATE HEALTHCARE PROVIDERS. CANCER CLINICAL TRIALS ENABLE PATIENTS TO BETTER UNDERSTAND AND PARTICIPATE IN THE MANAGEMENT OF THEIR DISEASE. THE ORGANIZATION'S MAIN SOURCES OF SUPPORT AND REVENUE ARE RECEIVED FROM CLINICAL TRIALS,NCORP AND CONTRIBUTIONS. DURING THE FISCAL YEAR ENDING JUNE 30, 2023, APPROXIMATELY 246 PATIENTS AND THEIR FAMILIES WERE ASSISTED.


Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.

Board, Officers & Key Employees

Name (title)Compensation
Michele Goodman
Co-Chair
$0
Carolyn Muller MD
Co-Chair
$0
Kristin Gates
Sec.treasurer
$0
Jessica Valdez MD
Director
$0
Ethan Binder MD
Director
$0
William Adler MD
Director
$0

Outside Vendors & Contractors

Vendor Name (Service)Compensation
Unm Cancer Center
Subject Fees For Clinical Trials & Parti
$1,546,172
Presbyterian
Clinical Trial Reviews
$130,822
Western Institutional Review Board
Clinical Trial Reviews
$156,612
View All Vendors

Financial Statements

Statement of Revenue
Federated campaigns$0
Membership dues$0
Fundraising events$0
Related organizations$0
Government grants $0
All other contributions, gifts, grants, and similar amounts not included above$1,220,450
Noncash contributions included in lines 1a–1f $0
Total Revenue from Contributions, Gifts, Grants & Similar$1,220,450
Total Program Service Revenue$195,713
Investment income $15,722
Tax Exempt Bond Proceeds $0
Royalties $0
Net Rental Income $0
Net Gain/Loss on Asset Sales $0
Net Income from Fundraising Events $0
Net Income from Gaming Activities $0
Net Income from Sales of Inventory $0
Miscellaneous Revenue$0
Total Revenue $1,431,885

Create an account to unlock the data you need.

or